DK3176270T3 - Forudsigelse af melanomcancerprognose - Google Patents

Forudsigelse af melanomcancerprognose Download PDF

Info

Publication number
DK3176270T3
DK3176270T3 DK16203301.3T DK16203301T DK3176270T3 DK 3176270 T3 DK3176270 T3 DK 3176270T3 DK 16203301 T DK16203301 T DK 16203301T DK 3176270 T3 DK3176270 T3 DK 3176270T3
Authority
DK
Denmark
Prior art keywords
prediction
cancer prognosis
melanoma cancer
melanoma
prognosis
Prior art date
Application number
DK16203301.3T
Other languages
English (en)
Inventor
Michael Alan Black
Jonathan Cebon
Parry John Guilford
Thomas John
Original Assignee
Pacific Edge Ltd
Ludwig Inst For Cancer Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacific Edge Ltd, Ludwig Inst For Cancer Res Ltd filed Critical Pacific Edge Ltd
Application granted granted Critical
Publication of DK3176270T3 publication Critical patent/DK3176270T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK16203301.3T 2007-05-24 2008-05-23 Forudsigelse af melanomcancerprognose DK3176270T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ555363A NZ555363A (en) 2007-05-24 2007-05-24 Prognosis prediction for melanoma cancer
EP08766967.7A EP2158332B1 (en) 2007-05-24 2008-05-23 Prognosis prediction for melanoma cancer

Publications (1)

Publication Number Publication Date
DK3176270T3 true DK3176270T3 (da) 2020-10-12

Family

ID=40032133

Family Applications (2)

Application Number Title Priority Date Filing Date
DK08766967.7T DK2158332T3 (da) 2007-05-24 2008-05-23 Prognoseforudsigelse til melanomcancer
DK16203301.3T DK3176270T3 (da) 2007-05-24 2008-05-23 Forudsigelse af melanomcancerprognose

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK08766967.7T DK2158332T3 (da) 2007-05-24 2008-05-23 Prognoseforudsigelse til melanomcancer

Country Status (17)

Country Link
US (3) US8822149B2 (da)
EP (2) EP3176270B1 (da)
JP (5) JP5943315B2 (da)
CN (1) CN101743327B (da)
AR (1) AR066725A1 (da)
AU (1) AU2008253836B2 (da)
CA (1) CA2725602A1 (da)
CL (1) CL2008001517A1 (da)
DK (2) DK2158332T3 (da)
ES (2) ES2622858T3 (da)
HK (1) HK1145342A1 (da)
NZ (1) NZ555363A (da)
PT (2) PT2158332T (da)
SG (2) SG10201912289SA (da)
TW (2) TWI582236B (da)
UY (1) UY31105A1 (da)
WO (1) WO2008143533A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120135415A1 (en) * 2002-11-15 2012-05-31 Morehouse School Of Medicine Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies
EP3851856A3 (en) 2007-03-27 2021-11-03 Immunovia AB Method, array and use thereof
JP5683280B2 (ja) * 2011-01-04 2015-03-11 株式会社日立製作所 診療支援システム
CN102617734B (zh) * 2011-12-28 2013-09-04 暨南大学 抗FGF-2抗体Dab-2及其应用
US9336302B1 (en) 2012-07-20 2016-05-10 Zuci Realty Llc Insight and algorithmic clustering for automated synthesis
US9355105B2 (en) * 2012-12-19 2016-05-31 International Business Machines Corporation Indexing of large scale patient set
EP2971085B1 (en) 2013-03-14 2018-08-08 Castle Biosciences Inc. Methods for predicting risk of metastasis in cutaneous melanoma
US10687711B2 (en) * 2015-05-05 2020-06-23 Medizinische Universität Wien Computerized device and method for processing image data
WO2018009887A1 (en) * 2016-07-08 2018-01-11 University Of Hawaii Joint analysis of multiple high-dimensional data using sparse matrix approximations of rank-1
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
US10692605B2 (en) 2018-01-08 2020-06-23 International Business Machines Corporation Library screening for cancer probability
TW202018727A (zh) 2018-11-09 2020-05-16 財團法人工業技術研究院 整體式學習預測方法與系統
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CN112200391B (zh) * 2020-11-17 2023-07-04 国网陕西省电力公司经济技术研究院 基于k-近邻互信息特征简化的配电网边缘侧负荷预测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101302627B1 (ko) 2005-01-05 2013-09-10 아비에 인코포레이티드 11-베타-하이드록시스테로이드 데하이드로게나제 타입 1 효소의 억제제
US8299216B2 (en) * 2005-01-07 2012-10-30 The Johns Hopkins University Biomarkers for melanoma
US7615349B2 (en) * 2006-09-07 2009-11-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. Melanoma gene signature
US9492518B2 (en) * 2006-10-04 2016-11-15 Dana-Farber Cancer Institute, Inc. Tumor immunity

Also Published As

Publication number Publication date
DK2158332T3 (da) 2017-05-01
HK1145342A1 (en) 2011-04-15
JP6404304B2 (ja) 2018-10-10
PT3176270T (pt) 2020-10-08
TWI582236B (zh) 2017-05-11
AR066725A1 (es) 2009-09-09
CL2008001517A1 (es) 2009-01-09
CA2725602A1 (en) 2008-11-27
EP2158332B1 (en) 2017-01-18
EP3176270B1 (en) 2020-07-08
JP2010527604A (ja) 2010-08-19
JP2019004907A (ja) 2019-01-17
ES2821300T3 (es) 2021-04-26
US8822149B2 (en) 2014-09-02
SG10201509568QA (en) 2015-12-30
PT2158332T (pt) 2017-04-26
ES2622858T3 (es) 2017-07-07
US10266902B2 (en) 2019-04-23
CN101743327A (zh) 2010-06-16
JP2017079765A (ja) 2017-05-18
TW201500553A (zh) 2015-01-01
UY31105A1 (es) 2009-01-05
US20170107583A1 (en) 2017-04-20
NZ555363A (en) 2009-11-27
JP2015061528A (ja) 2015-04-02
US20100136553A1 (en) 2010-06-03
EP2158332A1 (en) 2010-03-03
EP3176270A1 (en) 2017-06-07
TWI609967B (zh) 2018-01-01
AU2008253836A1 (en) 2008-11-27
CN101743327B (zh) 2013-04-24
JP5943315B2 (ja) 2016-07-05
WO2008143533A1 (en) 2008-11-27
SG10201912289SA (en) 2020-02-27
JP2020150949A (ja) 2020-09-24
US20150031578A1 (en) 2015-01-29
EP2158332A4 (en) 2011-01-05
AU2008253836B2 (en) 2014-11-27
US9534258B2 (en) 2017-01-03
TW200914623A (en) 2009-04-01

Similar Documents

Publication Publication Date Title
DK3176270T3 (da) Forudsigelse af melanomcancerprognose
DK2115472T3 (da) Cancerbiomarkører
DK2504451T3 (da) Fremgangsmåder til at forudsige det kliniske forløb af cancer
DK2325648T3 (da) Fremgangsmåde til detektering af cancer
DE602008003347D1 (de) Tonerverfahren
DK2278945T3 (da) Rektal drænindretning
DK2099973T3 (da) Udfoldning af gabion
BRPI1006075A2 (pt) biomarcadores de cancer
DK3106873T3 (da) Fremgangsmåde til detektering af cancer
DK2111555T3 (da) Diagnosticering af præeklampsi
DK2364166T3 (da) Undertrykkelse af cancer
FR2941796B3 (fr) Ordinateur portable
BRPI0920069A2 (pt) biomarcadores
HK1142128A1 (en) Methods of prognosis
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK2126602T3 (da) Tilvejebringelse af hjælpedata
BRPI0820154A2 (pt) Polia expansível
DK2081675T3 (da) Syntese af biodiesel
UY3776Q (es) Reloj pulsera
DK2142905T3 (da) Biomarkørnormalisering
ITPD20070110A1 (it) Struttura di tamburo
ITRA20070030A1 (it) Quaderno digitale
ES1065791Y (es) Cuaderno
FIU20070234U0 (fi) Kannettavan tietokoneen modeemin antenni
FI20061046A0 (fi) Syövän etäispesäkkeiden estäminen